Commentary: The unacceptable aortic risk with fluoroquinolone exposure in Marfan syndrome.
Balsam LB, Hoffman WD. Commentary: The unacceptable aortic risk with fluoroquinolone exposure in Marfan syndrome. J Thorac Cardiovasc Surg. 2022 03; 163(3):e227-e228.